BioCentury | Nov 25, 2013
Company News

Eli Lilly, Project A.L.S. deal

...The partners could not be reached for details. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Project A.L.S....
BioCentury | May 22, 2006
Company News

Columbia University, Project A.L.S. neurology news

...Under a JV, the university and Project A.L.S. opened a privately funded laboratory to focus on the...
...to screen candidates for ALS and spinal muscular atrophy. Columbia University , New York, N.Y. Project A.L.S....
BioCentury | Jun 16, 2003
Company News

Curis, Project A.L.S. deal

...CRIS and non-profit organization Project A.L.S. will develop treatments for amyotrophic lateral sclerosis based on the Hedgehog...
...development of motor nerve cells from progenitor or stem cells. Curis Inc. (CRIS), Cambridge, Mass. Project A.L.S....
Items per page:
1 - 3 of 3
BioCentury | Nov 25, 2013
Company News

Eli Lilly, Project A.L.S. deal

...The partners could not be reached for details. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Project A.L.S....
BioCentury | May 22, 2006
Company News

Columbia University, Project A.L.S. neurology news

...Under a JV, the university and Project A.L.S. opened a privately funded laboratory to focus on the...
...to screen candidates for ALS and spinal muscular atrophy. Columbia University , New York, N.Y. Project A.L.S....
BioCentury | Jun 16, 2003
Company News

Curis, Project A.L.S. deal

...CRIS and non-profit organization Project A.L.S. will develop treatments for amyotrophic lateral sclerosis based on the Hedgehog...
...development of motor nerve cells from progenitor or stem cells. Curis Inc. (CRIS), Cambridge, Mass. Project A.L.S....
Items per page:
1 - 3 of 3